CD8+ T cells rapidly up-regulate IFN-γ and TNFα expression upon activation (Fig. 7A), therefore, the locally produced IFN-γ and TNFα in the tumor microenvironment by tumor-infiltrating T cells should be non-toxic and yet effective sensitizers in TRAIL therapy. Here, CD8A is linked to neoplasm.